| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
|
| February 2010 - 78 products |
|
| L | | IP | | | Ondansetron Labatec,
4mg/2ml | 5 1 ampoule(s) à 2 ml | 30.90 | 50.00 | 10 % | | Concentrate for infusion: Ondansetronum 4mg / 2ml | Labatec Pharma SA | B / SL / SG | FB | G |
| L | | IP | | | Ondansetron Labatec,
8mg/4ml | 5 1 ampoule(s) à 4 ml | 57.55 | 79.00 | 10 % | | Concentrate for infusion: Ondansetronum 8mg / 4ml | Labatec Pharma SA | B / SL / SG | FB | G |
| L | | IP | | | Ceftriaxon Labatec 2 g
i.v. | 2 g | 9.90 | 27.20 | 10 % | | Dry substance: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / SL / SG | FB | G |
| L | | IP | | | Ceftriaxon Labatec 2 g
i.v. | 10 x 2 g | 84.15 | 107.95 | 10 % | | Dry substance: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / SL / SG | FB | G |
| | | IP | | | Vancomycin Labatec 500 mg | 500 mg | 10.89 | 28.25 | 10 % | | Dry substance: Vancomycinum 500 mg | Labatec Pharma SA | A / SL / SG | FB | G |
| L | | IP | | | Vancomycin Labatec 500 mg | 10 x 500 mg | 108.85 | 134.80 | 10 % | | Dry substance: Vancomycinum 500 mg | Labatec Pharma SA | A / SL / SG | FB | G |
| | | IP | | | Vancomycin Labatec 1 g | 1 g | 21.78 | 40.10 | 10 % | | Dry substance: Vancomycinum 1 g | Labatec Pharma SA | A / SL / SG | FB | G |
| L | | IP | | | Vancomycin Labatec 1 g | 10 x 1 g | 217.80 | 253.30 | 10 % | | Dry substance: Vancomycinum 1 g | Labatec Pharma SA | A / SL / SG | FB | G |
| | | IP | CI | | Cefuroxim Spirig HC 250 mg | 14 Tablet(s) | 9.15 | 26.35 | 10 % | | Coated tablets: Cefuroximum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | G |
| | | IP | CI | | Cefuroxim Spirig HC 500 mg | 14 Tablet(s) | 15.00 | 32.75 | 10 % | | Coated tablets: Cefuroximum 500 mg | Spirig HealthCare AG | A / SL / SG | FB | G |
| | | IP | CI | | Irbesartan Sandoz 150 | 28 Tablet(s) | 11.50 | 28.95 | 10 % | | Coated tablets: Irbesartanum 150 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan Sandoz 150 | 98 Tablet(s) | 37.12 | 56.95 | 10 % | | Coated tablets: Irbesartanum 150 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan Sandoz 300 | 28 Tablet(s) | 15.54 | 33.40 | 10 % | | Coated tablets: Irbesartanum 300 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Irbesartan Sandoz 300 | 98 Tablet(s) | 53.64 | 75.00 | 10 % | | Coated tablets: Irbesartanum 300 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Levofloxacin-Mepha Teva 250 mg | 5 | 6.53 | 16.35 | 10 % | | Coated tablets: Levofloxacinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | G |
| | | IP | CI | | Levofloxacin-Mepha Teva 250 mg | 7 | 8.61 | 25.80 | 10 % | | Coated tablets: Levofloxacinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | G |
| | | IP | CI | | Levofloxacin-Mepha Teva 250 mg | 10 | 11.52 | 28.95 | 10 % | | Coated tablets: Levofloxacinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | G |
| | | IP | CI | | Levofloxacin-Mepha Teva 500 mg | 5 | 9.83 | 27.10 | 10 % | | Coated tablets: Levofloxacinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | G |
| | | IP | CI | | Levofloxacin-Mepha Teva 500 mg | 7 | 12.93 | 30.50 | 10 % | | Coated tablets: Levofloxacinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | G |
| | | IP | CI | | Levofloxacin-Mepha Teva 500 mg | 10 | 17.33 | 35.25 | 10 % | | Coated tablets: Levofloxacinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | G |
| | | IP | CI | | Nebivolol Spirig HC | 28 Tablet(s) | 4.51 | 14.15 | 10 % | | Tablets: Nebivololum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Nebivolol Spirig HC | 56 Tablet(s) | 7.94 | 17.85 | 10 % | | Tablets: Nebivololum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Nebivolol Spirig HC | 98 Tablet(s) | 13.26 | 30.85 | 10 % | | Tablets: Nebivololum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Pramipexol-Mepha 0.125 mg | 30 | 4.98 | 14.65 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Pramipexol-Mepha 0.25 mg | 30 | 11.82 | 29.25 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Pramipexol-Mepha 0.25 mg | 100 | 33.33 | 52.65 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Pramipexol-Mepha 0.5 mg | 100 | 44.80 | 65.15 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Pramipexol-Mepha 1.0 mg | 100 | 114.50 | 140.95 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum 1 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | | | Ceftriaxon Labatec 1 g
i.v./i.m. | 1 g | 6.15 | 15.90 | 10 % | | poudre pour solution injectable: Ceftriaxonum 1000 mg | Labatec Pharma SA | A / SL / SG | FB | G |
| L | | IP | | | Ceftriaxon Labatec 1 g
i.v./i.m. | 10 x 1 g | 52.25 | 73.25 | 10 % | | poudre pour solution injectable: Ceftriaxonum 1000 mg | Labatec Pharma SA | A / SL / SG | FB | G |
| L | | IP | | V/S | Octagam 10 % | Flasche(n) | 132.67 | 160.70 | 10 % | | Injection solution: Proteina 100 mg/ml | Octapharma AG | B / SL | FB | G |
| L | | IP | | V/S | Octagam 10 % | Flasche(n) | 331.67 | 377.15 | 10 % | | Injection solution: Proteina 100 mg/ml | Octapharma AG | B / SL | FB | G |
| L | | IP | | V/S | Octagam 10 % | Flasche(n) | 663.33 | 737.85 | 10 % | | Injection solution: Proteina 100 mg/ml | Octapharma AG | B / SL | FB | G |
| L | | IP | | V/S | Octagam 10 % | Flasche(n) | 1326.67 | 1459.25 | 10 % | | Injection solution: Proteina 100 mg/ml | Octapharma AG | B / SL | FB | G |
| L | | IP | | V/S | Octagam 10 % | | 1990.00 | 2180.65 | 10 % | | Injection solution: Proteina 100 mg/ml | Octapharma AG | B / SL | FB | G |
| L | | IP | | | Zarzio 30 MU/0.5 ml | 5 syringe(s) | 293.98 | 335.45 | 10 % | | Injection solution in prefilled syringe: Filgrastimum | Sandoz
Pharmaceuticals AG | A / SL | FB | G |
| L | | IP | | | Zarzio 48 MU/0.5 ml | 5 syringe(s) | 413.81 | 465.50 | 10 % | | Injection solution in prefilled syringe: Filgrastimum | Sandoz
Pharmaceuticals AG | A / SL | FB | G |
| | | IP | | | Lucrin Depot 6 Monate | syringe(s) | 767.47 | 851.10 | 10 % | | Injection preparation: Leuprorelini Acetas 30 mg | AbbVie AG | A / SL | FB | G |
| | | IP | CI | Ph | Hyperiplant Rx | 40 Tablet(s) | 14.99 | 32.70 | 10 % | | Coated tablets: Hyperici Herbae Extractum Methanolicum Siccum 600 mg | Schwabe Pharma AG | B / SL | FB | G |
| | | IP | CI | Ph | Hyperiplant Rx | 100 Tablet(s) | 39.05 | 58.90 | 10 % | | Coated tablets: Hyperici Herbae Extractum Methanolicum Siccum 600 mg | Schwabe Pharma AG | B / SL | FB | G |
| L | | IP | CI | | Onglyza 2.5 mg | 28 Tablet(s) | 27.12 | 45.90 | 10 % | | Coated tablets: Saxagliptinum 2.5 mg | AstraZeneca AG | B / SL | FB | G |
| L | | IP | CI | | Onglyza 2.5 mg | 98 Tablet(s) | 92.37 | 116.85 | 10 % | | Coated tablets: Saxagliptinum 2.5 mg | AstraZeneca AG | B / SL | FB | G |
| L | | IP | CI | | Onglyza 5 mg | 28 Tablet(s) | 27.12 | 45.90 | 10 % | | Coated tablets: Saxagliptinum 5 mg | AstraZeneca AG | B / SL | FB | G |
| L | | IP | CI | | Onglyza 5 mg | 98 Tablet(s) | 92.37 | 116.85 | 10 % | | Coated tablets: Saxagliptinum 5 mg | AstraZeneca AG | ● B / SL | FB | G |
| | | IP | | | Firmagon 80 mg | Set(s) | 119.57 | 146.45 | 10 % | | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension (Lösungsmittel in Fertigspritze): Degarelixum 80 mg | Ferring AG | A / SL | FB | G |
| | | IP | | | Firmagon 120 mg | Set(s) | 245.66 | 283.60 | 10 % | | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension (Lösungsmittel in Fertigspritze): Degarelixum 120 mg | Ferring AG | A / SL | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 10 x 2 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 10 x 5 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 50 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 10 x 10 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 100 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 100 x 2 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 100 x 5 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 10 x 50 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 100 x 10 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Aqua ad iniectabilia
Amino | 10 x 100 ml | | | k.A. | | | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Glucose Amino 5% | 10 x 10 ml | | | k.A. | | Injection solution: Glucosum 50 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Glucose Amino 5% | 100 x 10 ml | | | k.A. | | Injection solution: Glucosum 50 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Glucose Amino 10% | 10 x 10 ml | | | k.A. | | Injection solution: Glucosum 100 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Glucose Amino 20% | 10 x 10 ml | | | k.A. | | Injection solution: Glucosum 200 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Glucose Amino 40% | 10 x 10 ml | | | k.A. | | Injection solution: Glucosum 400 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Glucose Amino 40% | 100 x 10 ml | | | k.A. | | Injection solution: Glucosum 400 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 10 x 2 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 10 x 5 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 50 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 10 x 10 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 100 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 100 x 2 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 100 x 5 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 10 x 50 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 100 x 10 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum 0,9%
Amino | 10 x 100 ml | | | k.A. | | Injection solution: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Patentblau V Guerbet | 5 1 ampoule(s) à 2 ml | | | k.A. | | Injection solution: Caeruleum Protectum V 25 mg/ml | Guerbet AG | B | FB | G |
| | | IP | | | Natrium chloratum Amino 10% | 10 x 10 ml | | | k.A. | | Konzentrat für Infusionslösungen: Natrii Chloridum 100 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Natrium chloratum Amino 20% | 10 x 10 ml | | | k.A. | | Konzentrat für Infusionslösungen: Natrii Chloridum 200 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | G |
| | | IP | | | Teicoplanin Labatec 200 mg | 200 mg | | | k.A. | | poudre pour solution injectable/pour perfusion: Teicoplaninum 200 mg | Labatec Pharma SA | A | FB | G |
| | | IP | | | Ceftriaxon Labatec 250 mg
i.m. | 10 x 250 mg | | | k.A. | | poudre pour solution injectable: Ceftriaxonum 250 mg | Labatec Pharma SA | A | FB | G |
| | | IP | | | Ceftriaxon Labatec 500 mg
i.v. | 10 x 500 mg | | | k.A. | | poudre pour solution injectable: Ceftriaxonum 500 mg | Labatec Pharma SA | A | FB | G |
